BBA Mats Grenner (b. 1971) has been elected to the Board of Directors of Histolab Products AB, effective 1 January 2026. Grenner has served as the CEO and owner of Nordic Medcom, a company specialising in dialysis products and services, for nearly 30 years. Additionally, he is co-owner of Dialysis International ApS. He brings profound expertise in medical solutions, healthcare markets and business operations to the board.

“Mats Grenner’s strategic perspective, entrepreneurial experience and practical business acumen will support Histolab’s mission and growth,” states Chair of the Board Alexander Bargum.

The Board of Directors of Histolab Products is composed of Chair Alexander Bargum and Members Johannes Bargum, Karin Dahllöf, Joakim Flinck, Karin Wingstrand and Mats Grenner.